Patent classifications
A61K35/63
Herbal formulations
The present invention relates to a formulation comprising Propolis, Ginseng root and Zingiber officinale extracts to be used in the treatment, prevention of various respiratory diseases or alleviation and/or elimination of symptoms thereof and a method for preparing said formulation.
Herbal formulations
The present invention relates to a formulation comprising Propolis, Ginseng root and Zingiber officinale extracts to be used in the treatment, prevention of various respiratory diseases or alleviation and/or elimination of symptoms thereof and a method for preparing said formulation.
GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES
GLP-2 analogues are disclosed which comprise one of more substitutions as compared to h[Gly2]GLP-2 and which may have the property of an altered GLP-1 activity, and their medical use. The analogues are particularly useful for the prophylaxis treatment or ameliorating of the gastro-intestinal associated side effects of diabetes.
GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES
GLP-2 analogues are disclosed which comprise one of more substitutions as compared to h[Gly2]GLP-2 and which may have the property of an altered GLP-1 activity, and their medical use. The analogues are particularly useful for the prophylaxis treatment or ameliorating of the gastro-intestinal associated side effects of diabetes.
Hydrogel toxin-absorbing or binding nanoparticles
The present invention provides for compositions comprising a polymeric hydrogel impregnated with a toxin-absorbing or binding nanoparticle. The present invention also provides for the use of the above compositions for decreasing or neutralizing the effect of a toxin, or for treating or preventing an infection by a microbe that produces a toxin, in a subject. The exemplary toxin is a biological toxin such as a viral, bacterial, fungal, plant or animal toxin.
Hydrogel toxin-absorbing or binding nanoparticles
The present invention provides for compositions comprising a polymeric hydrogel impregnated with a toxin-absorbing or binding nanoparticle. The present invention also provides for the use of the above compositions for decreasing or neutralizing the effect of a toxin, or for treating or preventing an infection by a microbe that produces a toxin, in a subject. The exemplary toxin is a biological toxin such as a viral, bacterial, fungal, plant or animal toxin.
Methods for making mixed allergen compositions
Methods of making mixed allergen compositions, e.g., substantially aerobic organism free mixed allergen compositions, and the resulting allergen composition, are provided.
Methods for making mixed allergen compositions
Methods of making mixed allergen compositions, e.g., substantially aerobic organism free mixed allergen compositions, and the resulting allergen composition, are provided.
Preparation for Treating Androgen Deficiency in Women
- Dmitriy G. Elistratov ,
- Villory I. Strukov ,
- Vyacheslav N. Trifonov ,
- Yuliya A. Elistratova ,
- Konstantin G. Elistratov ,
- Natalia V. Kurus' ,
- Alexander V. Fyodorov ,
- Evgeniy N. Krutyakov ,
- Elena S. Andreyeva ,
- Tatiana V. Elistratova ,
- Irina V. Khomyakova ,
- Galina A. Tolbina ,
- Galina V. Dolgushkina ,
- Alla N. Astafieva ,
- Tatiana A. Kuptsova ,
- Yuliya G. Shcherbakova ,
- Natalia M. Smirnova
A biologically active food additive, comprising drone brood homogenate in the daily amount of between 10 and 600 mg which can be combined with a calcium compound selected from calcium carbonate, calcium citrate, calcium gluconate, calcium aspartate, calcium amino acid chelate, calcium fumarate, calcium succinate, calcium ascorbate, calcium phosphate, or any combination thereof, the calcium compound content being from 16.67 to 93.75 wt. %; the content of drone brood being from 6.25 to 83.33 wt. %. Trials showed that administering the preparation contributes to the normalization of androgens in women resulting in the overall health improvement and disappearance or decrease of clinical signs of androgen deficiency, as well as sustaining the normal testosterone level, compensating for the deficit of calcium in the body, facilitating more efficient assimilation of calcium and retention thereof in the bony tissue for a long time.
Preparation for Treating Androgen Deficiency in Women
- Dmitriy G. Elistratov ,
- Villory I. Strukov ,
- Vyacheslav N. Trifonov ,
- Yuliya A. Elistratova ,
- Konstantin G. Elistratov ,
- Natalia V. Kurus' ,
- Alexander V. Fyodorov ,
- Evgeniy N. Krutyakov ,
- Elena S. Andreyeva ,
- Tatiana V. Elistratova ,
- Irina V. Khomyakova ,
- Galina A. Tolbina ,
- Galina V. Dolgushkina ,
- Alla N. Astafieva ,
- Tatiana A. Kuptsova ,
- Yuliya G. Shcherbakova ,
- Natalia M. Smirnova
A biologically active food additive, comprising drone brood homogenate in the daily amount of between 10 and 600 mg which can be combined with a calcium compound selected from calcium carbonate, calcium citrate, calcium gluconate, calcium aspartate, calcium amino acid chelate, calcium fumarate, calcium succinate, calcium ascorbate, calcium phosphate, or any combination thereof, the calcium compound content being from 16.67 to 93.75 wt. %; the content of drone brood being from 6.25 to 83.33 wt. %. Trials showed that administering the preparation contributes to the normalization of androgens in women resulting in the overall health improvement and disappearance or decrease of clinical signs of androgen deficiency, as well as sustaining the normal testosterone level, compensating for the deficit of calcium in the body, facilitating more efficient assimilation of calcium and retention thereof in the bony tissue for a long time.